Search - tctmd.com

Displaying 281 - 300 of 689

Sort: Relevancy | Date

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

New Targets: Heart Failure With Preserved Ejection Fraction

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

In Which Direction is Cell Based Heart Failure Therapy Headed?

Presenter: Francisco Fdez-Aviles, Emerson C. Perin

October 31, 2017

Presentation TCT 2017

TCT 571: Different Tissue Morphology of In-stent Restenosis in Hemodialysis Patient Compared With Non-hemodialysis Patients: A Prospective Multicenter Optical Coherence Tomography Registry

Presenter: Francesco Prati, Renu Virmani, Yoshinori Nagasawa, MD

October 31, 2017

Presentation TCT 2017

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz

October 31, 2017

Presentation TCT 2017

US Trial Background and Update: Preserve-AMI

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

TCT 94: Safety and Efficacy of the Combo Bioegineered Stent in an All-Comer PCI Cohort - Results From the Mascot Postmarketing Registry

Presenter: Francesco Prati, Renu Virmani, Antonio Colombo

October 31, 2017

Presentation TCT 2017

TCT 45: IV-OCT Virtual Histology: Automatic Identification of Human

Presenter: John McB. Hodgson, Akiko Maehara, Taylor Hoyt, MD

October 31, 2017

Presentation TCT 2017

TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings

Presenter: Francesco Prati, Renu Virmani, Abraham Tzafriri, MD

October 31, 2017

Presentation TCT 2017

Surgical vs Endovascular Treatment and Outcomes: Appropriate Use Considerations

Presenter: D. Christopher Metzger, Ido Weinberg, Peter A. Schneider

October 31, 2017

Presentation TCT 2017

Optimal Patient Selection for Mesenteric Stenting: Clinical and Anatomic Tips and Tricks

Presenter: D. Christopher Metzger, Ido Weinberg, Robert A. Lookstein

October 31, 2017

Presentation TCT 2017

Optimal Technique: Radial vs Femoral Access, and Optimizing Patency With Covered vs Bare Metal Stents

Presenter: D. Christopher Metzger, Ido Weinberg

October 31, 2017

Presentation TCT 2017

Pelvic Congestion Syndrome: Management and Developing an Office-Based Practice

Presenter: Brian G. DeRubertis, Bret N. Wiechmann

October 31, 2017

Presentation TCT 2017

Venous Interventions in the Office-Based Suite: Iliocaval, May Thurner Syndrome, and Other Deep Venous Procedures

Presenter: Brian G. DeRubertis, Bret N. Wiechmann, William H. Julien

October 31, 2017

Presentation TCT 2017

Evidence-Based Decision-making for Office-Based Endovascular Procedures

Presenter: Brian G. DeRubertis, Bret N. Wiechmann, Tony Das

October 31, 2017

Presentation TCT 2017

CLI and Lower Extremity Intervention: Devices and Techniques for Complex Disease in the Office Interventional Suites

Presenter: Brian G. DeRubertis, Bret N. Wiechmann

October 31, 2017

Presentation TCT 2017

Management of Unilateral RAS With Uncontrolled Hypertension on Three Meds: Pro Additional Medical Management

Presenter: Robert D. Safian, Christopher J. White, Christopher J. Cooper

October 31, 2017

Presentation TCT 2017

Outpatient Same Day PCI and CRM Procedures

Presenter: Brian G. DeRubertis, Bret N. Wiechmann, Jeffrey G. Carr

October 31, 2017

Presentation TCT 2017

Management of Unilateral RAS With Uncontrolled Hypertension on Three Meds: Pro Renal Stenting

Presenter: Robert D. Safian, Christopher J. White, Mark C. Bates

October 31, 2017

Advertisement

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

New Targets: Heart Failure With Preserved Ejection Fraction

In Which Direction is Cell Based Heart Failure Therapy Headed?

TCT 571: Different Tissue Morphology of In-stent Restenosis in Hemodialysis Patient Compared With Non-hemodialysis Patients: A Prospective Multicenter Optical Coherence Tomography Registry

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

US Trial Background and Update: Preserve-AMI

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

TCT 94: Safety and Efficacy of the Combo Bioegineered Stent in an All-Comer PCI Cohort - Results From the Mascot Postmarketing Registry

TCT 45: IV-OCT Virtual Histology: Automatic Identification of Human

TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings

Surgical vs Endovascular Treatment and Outcomes: Appropriate Use Considerations

Optimal Patient Selection for Mesenteric Stenting: Clinical and Anatomic Tips and Tricks

Optimal Technique: Radial vs Femoral Access, and Optimizing Patency With Covered vs Bare Metal Stents

Pelvic Congestion Syndrome: Management and Developing an Office-Based Practice

Venous Interventions in the Office-Based Suite: Iliocaval, May Thurner Syndrome, and Other Deep Venous Procedures

Evidence-Based Decision-making for Office-Based Endovascular Procedures

CLI and Lower Extremity Intervention: Devices and Techniques for Complex Disease in the Office Interventional Suites

Management of Unilateral RAS With Uncontrolled Hypertension on Three Meds: Pro Additional Medical Management

Outpatient Same Day PCI and CRM Procedures

Management of Unilateral RAS With Uncontrolled Hypertension on Three Meds: Pro Renal Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content